In an on-going overhaul of NASA's Artemis program, agency officials say it will take seven years to build a sophisticated ...
Novo Nordisk’s GLP-1/amylin combo has failed to beat Eli Lilly’s obesity blockbuster Zepbound in a phase 3 weight loss study, further denting the Danish pharma’s attempts to reclaim its obesity crown.
Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...
Morning Overview on MSN
Radiation-hardened Wi-Fi chip survives 500 kGy for cleanup robots
Researchers at the Institute of Science Tokyo have developed a Wi-Fi chip that continued to function after absorbing 500 ...
A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.
NEW YORK, March 4, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Ultragenyx Pharmaceutical Inc. (RARE) securities of a pending securities class action. Investors have until April 6, ...
The Space Coast ended 2025 with a record 109 launches from SpaceX, United Launch Alliance and Blue Origin. 2026 could see a ...
Just under four months after Soyuz MS-28 launched from Site 31/6 at Baikonur Cosmodrome in Kazakhstan, an eventful flight ...
More than 20 years after Operation Red Wings, the mission that inspired the bestselling memoir and film “Lone Survivor,” Navy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results